Pharmacological actions of statins: potential utility in COPD
Authors:
- R. P. YoungRYR. P. Young
- R. HopkinsRHR. Hopkins
- T. E. EatonTET. E. Eaton
Open Access
- 30 November 2009
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 18 (114) , 222-232
Abstract
Chronic obstructive pulmonary disease (COPD) is characterised by minimally reversible airflow limitation and features of systemic inflammation. Current therapies for COPD have been shown to reduce symptoms and infective exacerbations and to improve quality of life. However, these drugs have little effect on the natural history of the disease (progressive decline in lung function and exercise tolerance) and do not improve mortality. The anti-inflammatory effects of statins on both pulmonary and systemic inflammation through inhibition of guanosine triphosphatase and nuclear factor-κB mediated activation of inflammatory and matrix remodelling pathways could have substantial benefits in patients with COPD due to the following. 1) Inhibition of cytokine production (tumour necrosis factor-α, interleukin (IL)-6 and IL-8) and neutrophil infiltration into the lung; 2) inhibition of the fibrotic activity in the lung leading to small airways fibrosis and irreversible airflow limitation; 3) antioxidant and anti-inflammatory (IL-6 mediated) effects on skeletal muscle; 4) reduced inflammatory response to pulmonary infection; and 5) inhibition of the development (or reversal) of epithelial-mesenchymal transition, a precursor event to lung cancer. This review examines the pleiotropic pharmacological action of statins which inhibit key inflammatory and remodelling pathways in COPD and concludes that statins have considerable potential as adjunct therapy in COPD.Keywords
This publication has 119 references indexed in Scilit:
- Associations of IL6 polymorphisms with lung function decline and COPDThorax, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Nature Genetics, 2008
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI: Journal of the National Cancer Institute, 2008
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Potential therapeutic role for statins in respiratory diseaseThorax, 2006
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJACC, 2006
- Pathogenesis of COPDSeminars in Respiratory and Critical Care Medicine, 2005
- To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosisOncogene, 2003